MBIO (Mustang Bio) Nilai bisnis marang pendapatan

Logo perusahaan publik Mustang Bio, Inc. (MBIO)

This chart of the company's enterprise value-to-revenue ratio illustrates the valuation trend, where the current mark is 0.00. Mustang Bio, Inc. (MBIO) focuses on developing gene therapies to combat rare pathologies and cancer, generating revenue through CAR-T technology partnerships. However, stringent FDA regulations and a shortage of R&D funding are hindering development, while geopolitical instability complicates component logistics and the execution of trials.

MBIO Mustang Bio Inc: Rasio nilai perusahaan marang pendapatan ing interval 23.11.2025 - 20.11.2026

Rincian metrik keuangan lan pasar Mustang Bio Inc (MBIO)

- rega lan prakiraan konsensus rega:
- indikator valuasi pasar bisnis:
Analisis wiwitan perusahaan:Mustang Bio, Inc.
Produk asil prodhuksi Mustang Bio

This ratio compares the total enterprise value, including debt and market capitalization, with the volume of generated revenue to determine an objective market revaluation of the asset. By analyzing the EV/Sales history, an investor can assess the capitalization efficiency of Mustang Bio, Inc. developments, which are supported by a stable US financial base and an absence of geopolitical risks in the cell therapy sector.

Analisis pesaing Mustang Bio, Inc.

TEM (tempus.com) - Rasio nilai perusahaan marang pendapatan|qiagen.com (QGEN) - Rasio nilai perusahaan marang pendapatan|Ionis (IONS) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan Repligen|Avidity (RNA) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales CRSP|Rasio total nilai perusahaan marang pendapatan GeneDx|Rasio nilai perusahaan marang pendapatan Ultragenyx RARE|Rasio total nilai perusahaan marang pendapatan Beam Therapeutics (BEAM)|SRPT: Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Twist Bioscience|TXG (10x Genomics) - Nilai perusahaan marang pendapatan|Intellia Therapeutics, Inc. (NTLA) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan Stoke Therapeutics Inc|BLFS: Nilai bisnis marang pendapatan|Nilai perusahaan marang pendapatan WVE (Wave Life Sciences Corp)|Rasio total nilai perusahaan marang pendapatan Maze Therapeutics Corp|Sionna Therapeutics Inc - Nilai perusahaan marang pendapatan|PRME (primemedicine.com) - Nilai perusahaan marang volume dodolan|TSHA - Rasio nilai perusahaan marang pendapatan|QURE (uniQure) - Rasio nilai perusahaan marang pendapatan|MeiraGTx Corp (MGTX) - Rasio nilai perusahaan marang pendapatan|Regenxbio - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan solidbio.com|Multiplikator nilai perusahaan marang pendapatan ocugen.com OCGN|Multiplikator EV/Sales PACB|Benitec - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Design Therapeutics DSGN|Multiplikator EV/Sales Rocket Pharmaceuticals RCKT|Nilai perusahaan marang volume dodolan 4D Molecular Corp|LXEO: Rasio nilai perusahaan marang pendapatan|KRRO (Korro Bio, Inc) - Nilai perusahaan marang pendapatan|Editas Medicine (EDIT) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan Silence Therapeutics Inc.|Rasio nilai perusahaan marang pendapatan PRQR (proqr.com)|Rasio nilai perusahaan marang pendapatan Codexis Bio (CDXS)|Multiplikator EV/Sales sangamo.com (SGMO)|Rasio nilai perusahaan marang pendapatan nautilus.bio NAUT|Rasio total nilai perusahaan marang pendapatan Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Multiplikator EV/Sales|GBIO - Multiplikator EV/Sales|BOLD: Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan XCUR|Rasio nilai perusahaan marang pendapatan Imunon|Phio Pharmaceuticals - Nilai perusahaan marang volume dodolan|Rasio nilai perusahaan marang pendapatan TransCode (RNAZ)|Bionano Genomics Inc. - Rasio nilai perusahaan marang pendapatan|Applied DNA Sciences - Nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan bluebirdbio.com (BLUE)|IPA - Rasio nilai perusahaan marang pendapatan|OMGA - Multiplikator EV/Sales|OMIC (Singular Genomics Systems, Inc.) - Nilai perusahaan marang pendapatan|Regulus Therapeutics Inc - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Syros Pharmaceuticals|Nilai perusahaan marang pendapatan Telesis Bio (TBIO)|Multiplikator EV/Sales TCON|UBX - Multiplikator nilai perusahaan marang pendapatan